RU2004129752A - Гетероциклические амидные промзводные для лечения диабета и других заболеваний - Google Patents
Гетероциклические амидные промзводные для лечения диабета и других заболеваний Download PDFInfo
- Publication number
- RU2004129752A RU2004129752A RU2004129752/04A RU2004129752A RU2004129752A RU 2004129752 A RU2004129752 A RU 2004129752A RU 2004129752/04 A RU2004129752/04 A RU 2004129752/04A RU 2004129752 A RU2004129752 A RU 2004129752A RU 2004129752 A RU2004129752 A RU 2004129752A
- Authority
- RU
- Russia
- Prior art keywords
- compound according
- carbon atoms
- alkyl
- oxo
- substituted
- Prior art date
Links
- 0 **N(C(C=I)=C(C=I)N(*)C1=O)C1=O Chemical compound **N(C(C=I)=C(C=I)N(*)C1=O)C1=O 0.000 description 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36270202P | 2002-03-08 | 2002-03-08 | |
| US60/362,702 | 2002-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2004129752A true RU2004129752A (ru) | 2005-05-10 |
Family
ID=27805215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004129752/04A RU2004129752A (ru) | 2002-03-08 | 2003-03-07 | Гетероциклические амидные промзводные для лечения диабета и других заболеваний |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7102000B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1487443A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005530705A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050006126A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1649586A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003225682A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2478342A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL163952A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04008733A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20044250L (cg-RX-API-DMAC7.html) |
| RU (1) | RU2004129752A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200306184A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003075924A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200408057B (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1384825A (zh) * | 1999-08-31 | 2002-12-11 | 马克西亚药品公司 | 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用 |
| BR0207846A (pt) * | 2001-03-07 | 2005-09-13 | Incyte San Diego Inc | Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas |
| JP2004523571A (ja) * | 2001-03-08 | 2004-08-05 | マキシア・ファーマシューティカルズ・インコーポレイテッド | Rxr活性化分子 |
| EP1421061A4 (en) * | 2001-08-17 | 2004-12-22 | Incyte San Diego Inc | OXIME DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA AND HYPERCHOLESTEROLEMIA |
| US7196108B2 (en) * | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
| US7102000B2 (en) | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| BRPI0409501A (pt) * | 2003-04-18 | 2006-04-18 | Incyte San Diego Inc | compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças |
| EP1566202A1 (en) * | 2004-02-23 | 2005-08-24 | Sahltech I Göteborg AB | Use of resistin antagonists in the treatment of rheumatoid arthritis |
| US7122700B2 (en) | 2004-07-30 | 2006-10-17 | Xerox Corporation | Arylamine processes |
| GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
| DE602005020646D1 (de) * | 2004-08-30 | 2010-05-27 | Takeda Pharmaceutical | Screening-verfahren |
| CN101316821A (zh) | 2005-09-30 | 2008-12-03 | 詹森药业有限公司 | 作为rxr激动剂用于治疗异常脂肪血症、高胆固醇血症和糖尿病的二氢-[1h]-喹啉-2-酮衍生物 |
| ATE536347T1 (de) | 2008-05-20 | 2011-12-15 | Merck Sharp & Dohme | Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren |
| WO2012153775A1 (ja) | 2011-05-10 | 2012-11-15 | 国立大学法人神戸大学 | Ras機能阻害作用を有するチオキソチアゾリジン誘導体 |
| EP3062819B1 (en) | 2013-11-03 | 2021-12-22 | The Regents of The University of California | Ionic liquids for transdermal drug delivery |
| EP3467459B1 (en) * | 2016-06-07 | 2020-11-25 | Mitsubishi Electric Corporation | Temperature estimation method |
| US10912834B2 (en) | 2016-08-29 | 2021-02-09 | The Regents Of The University Of California | Topical formulations based on ionic species for skin treatment |
| US10828265B2 (en) | 2016-12-09 | 2020-11-10 | The Regents Of The University Of California | Formulations of propranolol and analogs as an amorphous melt or ionic liquid for transdermal drug delivery |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4051842A (en) | 1975-09-15 | 1977-10-04 | International Medical Corporation | Electrode and interfacing pad for electrical physiological systems |
| DE2626348C3 (de) | 1976-06-11 | 1980-01-31 | Siemens Ag, 1000 Berlin Und 8000 Muenchen | Implantierbare Dosiereinrichtung |
| JPS5538359A (en) | 1978-09-12 | 1980-03-17 | Hamari Yakuhin Kogyo Kk | Preparation of 2-(3-benzoylphenyl)-propionic acid |
| US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
| IL72684A (en) | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
| US4713244A (en) | 1985-08-16 | 1987-12-15 | Bausch & Lomb Incorporated | Sustained-release formulation containing an amino acid polymer with a lower alkyl (C1 -C4) polar solvent |
| US4931279A (en) | 1985-08-16 | 1990-06-05 | Bausch & Lomb Incorporated | Sustained release formulation containing an ion-exchange resin |
| US4668506A (en) | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
| CA1325222C (en) | 1985-08-23 | 1993-12-14 | Lederle (Japan), Ltd. | Process for producing 4-biphenylylacetic acid |
| DE3874257T2 (de) | 1987-03-11 | 1993-02-11 | Kanegafuchi Chemical Ind | Hydroxystyren-derivate. |
| JPS63230689A (ja) * | 1987-03-18 | 1988-09-27 | Tanabe Seiyaku Co Ltd | ベンゾオキサジン誘導体 |
| FI91869C (fi) * | 1987-03-18 | 1994-08-25 | Tanabe Seiyaku Co | Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi |
| US5330998A (en) | 1988-03-08 | 1994-07-19 | Pfizer Inc. | Thiazolidinedione derivatives as hypoglycemic agents |
| US5223522A (en) | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
| IE940525L (en) | 1988-05-25 | 1989-11-25 | Warner Lambert Co | Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents |
| EP0595868B1 (en) | 1991-07-22 | 1998-11-25 | Pfizer Inc. | Process for the preparation of (s)-4-[3-(5-methyl-2-phenyl-4-oxazolyl)- 1-hydroxypropyl]bromobenzene |
| DE69333894D1 (de) | 1992-04-22 | 2005-12-01 | Ligand Pharm Inc | Verbindungen mit Retinoid x rezeptorselektivität |
| US5780676A (en) | 1992-04-22 | 1998-07-14 | Ligand Pharmaceuticals Incorporated | Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
| CZ181493A3 (en) | 1992-09-10 | 1994-03-16 | Lilly Co Eli | The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease |
| WO1994012880A2 (en) | 1992-11-25 | 1994-06-09 | La Jolla Cancer Research Foundation | Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |
| DE4317320A1 (de) | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
| ES2130597T3 (es) | 1994-02-17 | 1999-07-01 | American Home Prod | Derivados de bifenilo sustituido como inhibidores de la fosfodiesterasa. |
| US5691376A (en) | 1994-02-17 | 1997-11-25 | American Home Products Corporation | Substituted biphenyl derivatives |
| JPH09136877A (ja) | 1995-06-16 | 1997-05-27 | Takeda Chem Ind Ltd | 複素環化合物、その製造法及び用途 |
| CA2223489A1 (en) | 1995-07-17 | 1997-02-06 | Joseph A. Fontana | Method for treating cancer using ahpn |
| JPH09176162A (ja) | 1995-12-22 | 1997-07-08 | Toubishi Yakuhin Kogyo Kk | チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物 |
| WO1997027191A1 (en) | 1996-06-19 | 1997-07-31 | Dr. Reddy's Research Foundation | Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation |
| US6127415A (en) | 1996-07-08 | 2000-10-03 | Galderma Research & Development, S.N.C. | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| CA2300813A1 (en) | 1997-08-21 | 1999-03-04 | Hiroyuki Odaka | Anti-inflammatory agent |
| EP1048659A4 (en) | 1997-11-12 | 2002-11-20 | Inst Med Molecular Design Inc | Retinoid receptor Antagonist |
| US6262044B1 (en) | 1998-03-12 | 2001-07-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPASES) |
| US6331633B1 (en) | 1998-05-08 | 2001-12-18 | Calyx Therapeutics Inc. | Heterocyclic analogs of diphenylethylene compounds |
| IL141456A0 (en) | 1998-08-21 | 2002-03-10 | Viropharma Inc | Rhodanine derivatives and pharmaceutical compositions containing the same |
| WO2000018748A1 (en) | 1998-09-30 | 2000-04-06 | Roche Diagnostics Gmbh | Rhodanine derivatives for the treatment and prevention of metabolic bone disorders |
| AU3111700A (en) | 1998-12-04 | 2000-06-19 | Structural Bioinformatics Inc. | Methods and compositions for treating inflammatory diseases utilizing inhibitorsof tumor necrosis factor activity |
| AU3958200A (en) | 1999-04-20 | 2000-11-02 | Novo Nordisk A/S | New compounds, their preparation and use |
| US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
| CN1384825A (zh) | 1999-08-31 | 2002-12-11 | 马克西亚药品公司 | 亚苄基-噻唑烷二酮及其类似物以及它们在治疗糖尿病中的应用 |
| PT1142885E (pt) | 1999-11-12 | 2007-02-28 | Fujimoto Brothers Co Ltd | Derivados de 2-(n-cianoimino)tiazolidin-4-ona |
| FR2812876B1 (fr) | 2000-08-08 | 2002-09-27 | Galderma Res & Dev | Nouveaux composes bi-aromatiques activateurs des recepteurs de type ppar-gamma et leur utilisation dans des compositions cosmetiques ou pharmaceutiques |
| BR0207846A (pt) | 2001-03-07 | 2005-09-13 | Incyte San Diego Inc | Derivados heterocìclicos para o tratamento de câncer e outras doenças proliferativas |
| JP2004523571A (ja) | 2001-03-08 | 2004-08-05 | マキシア・ファーマシューティカルズ・インコーポレイテッド | Rxr活性化分子 |
| AU2002258550B2 (en) | 2001-03-14 | 2006-04-27 | Eli Lilly And Company | Retinoid X receptor modulators |
| JP4590158B2 (ja) | 2001-04-04 | 2010-12-01 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | グルコース再吸収阻害剤およびレチノイド−x受容体モジュレーターを含んで成る併用療法 |
| EP1421061A4 (en) | 2001-08-17 | 2004-12-22 | Incyte San Diego Inc | OXIME DERIVATIVES FOR THE TREATMENT OF DYSLIPIDEMIA AND HYPERCHOLESTEROLEMIA |
| JP2005513026A (ja) | 2001-11-15 | 2005-05-12 | インサイト サン ディエゴ インコーポレイテッド | 高コレステロール血症、異脂肪血症および他の代謝障害;癌、および他の疾患を治療するn−置換複素環 |
| TW200304375A (en) | 2001-12-06 | 2003-10-01 | Maxia Pharmaceuticals Inc | 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer |
| US7196108B2 (en) | 2002-03-08 | 2007-03-27 | Incyte San Diego Inc. | Bicyclic heterocycles for the treatment of diabetes and other diseases |
| US7102000B2 (en) | 2002-03-08 | 2006-09-05 | Incyte San Diego Inc. | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| US20050014767A1 (en) | 2003-01-29 | 2005-01-20 | Magnus Pfahl | Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
| BRPI0409501A (pt) | 2003-04-18 | 2006-04-18 | Incyte San Diego Inc | compostos isocromanos substituìdos para o tratamento de desordens metabólicas, de cáncer e de outras doenças |
-
2003
- 2003-03-06 US US10/384,352 patent/US7102000B2/en not_active Expired - Fee Related
- 2003-03-07 JP JP2003574198A patent/JP2005530705A/ja active Pending
- 2003-03-07 CN CNA038101483A patent/CN1649586A/zh active Pending
- 2003-03-07 KR KR10-2004-7014099A patent/KR20050006126A/ko not_active Withdrawn
- 2003-03-07 CA CA002478342A patent/CA2478342A1/en not_active Abandoned
- 2003-03-07 TW TW092105025A patent/TW200306184A/zh unknown
- 2003-03-07 ZA ZA200408057A patent/ZA200408057B/en unknown
- 2003-03-07 IL IL16395203A patent/IL163952A0/xx unknown
- 2003-03-07 MX MXPA04008733A patent/MXPA04008733A/es unknown
- 2003-03-07 AU AU2003225682A patent/AU2003225682A1/en not_active Abandoned
- 2003-03-07 WO PCT/US2003/006784 patent/WO2003075924A1/en not_active Ceased
- 2003-03-07 EP EP03744197A patent/EP1487443A4/en not_active Withdrawn
- 2003-03-07 RU RU2004129752/04A patent/RU2004129752A/ru not_active Application Discontinuation
-
2004
- 2004-10-07 NO NO20044250A patent/NO20044250L/no unknown
-
2006
- 2006-06-28 US US11/476,330 patent/US20060241138A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1649586A (zh) | 2005-08-03 |
| NO20044250L (no) | 2004-11-03 |
| EP1487443A4 (en) | 2006-04-12 |
| EP1487443A1 (en) | 2004-12-22 |
| KR20050006126A (ko) | 2005-01-15 |
| IL163952A0 (en) | 2005-12-18 |
| US20030216432A1 (en) | 2003-11-20 |
| CA2478342A1 (en) | 2003-09-18 |
| US7102000B2 (en) | 2006-09-05 |
| US20060241138A1 (en) | 2006-10-26 |
| JP2005530705A (ja) | 2005-10-13 |
| MXPA04008733A (es) | 2006-07-03 |
| TW200306184A (en) | 2003-11-16 |
| AU2003225682A2 (en) | 2003-09-22 |
| ZA200408057B (en) | 2007-05-30 |
| AU2003225682A1 (en) | 2003-09-22 |
| WO2003075924A1 (en) | 2003-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5391565A (en) | Oxazolidine dione derivatives | |
| DE60103976T2 (de) | Pyrimidinylcarboxamiden als inhibitoren der pde4 isoenzyme | |
| DE60203652T2 (de) | Nikotinsäureamid-Derivate und ihre Mimetika als Inhibitoren von PDE4-Isozyme | |
| JP2005513026A5 (cg-RX-API-DMAC7.html) | ||
| JP2005530705A5 (cg-RX-API-DMAC7.html) | ||
| JP2817840B2 (ja) | 置換チアゾリジンジオン誘導体の製造方法 | |
| Lohray et al. | Novel euglycemic and hypolipidemic agents. 1 | |
| WO2001074771A1 (en) | Pyrrole-2,5-dione derivatives for the treatment of diabetes | |
| JP2005525371A5 (cg-RX-API-DMAC7.html) | ||
| EP3478677B1 (en) | 1h-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof | |
| JP2972377B2 (ja) | カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物 | |
| US5599826A (en) | Thiazolidinediones and drugs containing them | |
| Mourão et al. | Synthesis and biological activity of novel acridinylidene and benzylidene thiazolidinediones | |
| RU98117628A (ru) | Замещенные производные тиазолидиндиона, способ их получения, фармкомпозиция | |
| Storr et al. | Vanadyl− Thiazolidinedione Combination Agents for Diabetes Therapy | |
| LV12686A (en) | Method for treating diabetes employing an ap2 inhibitor and combination | |
| JP2005520858A (ja) | 置換フェニル酢酸 | |
| KR940019699A (ko) | 옥사졸리딘디온 유도체, 그의 제조방법 및 용도 | |
| MX2013010276A (es) | Derivados de fluoro-piridinona utiles como agentes antibacterianos. | |
| HUT70153A (en) | Hypoglycemic hydroxyurea derivatives | |
| RU2009140769A (ru) | Конденсированное бициклическое гетероарильное соединение | |
| WO2024137724A1 (en) | Inhibitors of protein tyrosine phosphatase, compositions, and methods of use | |
| CN119562951A (zh) | N-(2-(4-氰基噻唑烷-3-基)-2-氧代乙基)-喹啉-4-甲酰胺 | |
| JP2023123607A (ja) | ベンゼン誘導体 | |
| US20030216432A1 (en) | Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20080213 |